Xu Xiaolin, Wei Wen Bin, Li Bin, Gao Fei, Zhang Zhibao, Jonas Jost B
Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing, China.
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
PLoS One. 2014 Oct 3;9(10):e109699. doi: 10.1371/journal.pone.0109699. eCollection 2014.
To examine whether GNAQ and GNA11 somatic mutations previously identified in uveal melanomas of Caucasians are associated with uveal melanomas in Chinese patients.
Uveal melanomas treated by primary enucleation in Chinese patients underwent a mutation analysis of GNAQ and GNA11 with sequencing of exon 5 and exon 4.
The study included 50 patients with uveal melanoma and with a mean age of 47.6±13.0 years. During the follow-up of at least 3 years, 20 (40%) patients developed extraocular metastases. The frequencies of GNAQ and GNA11 somatic mutations in uveal melanoma were 18% (9/50) and 20% (10/50), respectively. The mutations occurred exclusively in codon 209 of exon 5. No mutations were detected in exon 4. Mutations affecting codon 209 in GNAQ were c.626A>C(Q209P) (78%) and c.626A>T(Q209L) (22%). Mutations affecting codon 209 in GNA11 were exclusively c.626A>T(Q209L) (100%). In none of the tumors, mutations of BRAF and NRAS were detected. GNAQ/11 mutations were marginally (P = 0.045) associated with optic disc involvement. In Kaplan-Meier analysis, metastasis-free survival was not significantly (P = 0.94) associated with GNAQ/11 mutations.
Mutations of GNAQ and GNA11 can be found in Chinese patients as in Caucasian patients with uveal melanoma, with a higher frequency reported for Caucasian patients.
研究先前在白种人葡萄膜黑色素瘤中鉴定出的GNAQ和GNA11体细胞突变是否与中国患者的葡萄膜黑色素瘤相关。
对中国患者因原发性眼球摘除术治疗的葡萄膜黑色素瘤进行GNAQ和GNA11的突变分析,对第5外显子和第4外显子进行测序。
该研究纳入了50例葡萄膜黑色素瘤患者,平均年龄为47.6±13.0岁。在至少3年的随访期间,20例(40%)患者发生了眼外转移。葡萄膜黑色素瘤中GNAQ和GNA11体细胞突变的频率分别为18%(9/50)和20%(10/50)。这些突变仅发生在第5外显子的第209密码子。在第4外显子中未检测到突变。影响GNAQ第209密码子的突变是c.626A>C(Q209P)(78%)和c.626A>T(Q209L)(22%)。影响GNA11第209密码子的突变仅为c.626A>T(Q209L)(100%)。在所有肿瘤中均未检测到BRAF和NRAS的突变。GNAQ/11突变与视盘受累存在边缘性关联(P = 0.045)。在Kaplan-Meier分析中,无转移生存期与GNAQ/11突变无显著关联(P = 0.94)。
与白种人葡萄膜黑色素瘤患者一样,中国患者也可检测到GNAQ和GNA11突变,白种人患者的突变频率更高。